Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibition of histone deacetylase as a treatment for cardiac hypertrophy

Inhibition of histone deacetylase as a treatment for cardiac hypertrophy

US Patent 6946441 · Granted Sep 20, 2005

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions involving bucindolol for the treatment of atrial fibril2025
Use of a small native peptide activator of SERCA pump for treatment of heart fai2025
Methods and compositions involving bucindolol for the treatment of atrial fibril2023
Compositions and methods relating to myomaker-induced muscle cell fusion2022
Methods and compositions involving (S)-bucindolol2022
NURR1 activation in the treatment of metabolic disorders and as an exercise mime2021
Use of a small native peptide activator of SERCA pump for treatment of heart fai2021
Methods and compositions involving bucindolol for the treatment of atrial fibril2021
Generation and correction of a humanized mouse model with a deletion of dystroph2020
Use of a small native peptide activator of SERCA pump for treatment of heart fai2020
High efficiency reprogramming of fibroblasts into cardiomyocytes2019
Micro-RNA family that modulates extracellular matrix genes and uses thereof2019